爱泼斯坦-巴尔病毒
病毒
生物
免疫系统
疾病
癌症
基因
免疫疗法
免疫学
基因组
病毒学
医学
癌症研究
遗传学
病理
出处
期刊:Annual Review of Pathology-mechanisms of Disease
[Annual Reviews]
日期:2019-01-24
卷期号:14 (1): 29-53
被引量:297
标识
DOI:10.1146/annurev-pathmechdis-012418-013023
摘要
Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide, and viral genes are expressed in the malignant cells. EBV also very efficiently causes the proliferation of infected human B lymphocytes. The functions of the viral proteins and small RNAs that may contribute to EBV-associated cancers are becoming increasingly clear, and a broader understanding of the sequence variation of the virus genome has helped to interpret their roles. The improved understanding of the mechanisms of these cancers means that there are great opportunities for the early diagnosis of treatable stages of EBV-associated cancers and the use of immunotherapy to target EBV-infected cells or overcome immune evasion. There is also scope for preventing disease by immunization and for developing therapeutic agents that target the EBV gene products expressed in the cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI